Chemical Compound Review:
Galardin (2R)-N'-hydroxy-N-[(1S)-2- (1H-indol-3-yl)...
Synonyms:
Ilomastat, Galardin MPI, CHEMBL19611, CS-610, BSPBio_001079, ...
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. Gijbels, K., Galardy, R.E., Steinman, L. J. Clin. Invest. (1994)
- Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells. Annabi, B., Thibeault, S., Moumdjian, R., Béliveau, R. J. Biol. Chem. (2004)
- Inhibition of human skin fibroblast collagenase, thermolysin, and Pseudomonas aeruginosa elastase by peptide hydroxamic acids. Grobelny, D., Poncz, L., Galardy, R.E. Biochemistry (1992)
- Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells. Kocer, S.S., Walker, S.G., Zerler, B., Golub, L.M., Simon, S.R. Infect. Immun. (2005)
- Matrix metalloproteinase inhibition modulates postoperative scarring after experimental glaucoma filtration surgery. Wong, T.T., Mead, A.L., Khaw, P.T. Invest. Ophthalmol. Vis. Sci. (2003)
- Tissue inhibitor of metalloproteinase-2 stimulates mesenchymal growth and regulates epithelial branching during morphogenesis of the rat metanephros. Barasch, J., Yang, J., Qiao, J., Tempst, P., Erdjument-Bromage, H., Leung, W., Oliver, J.A. J. Clin. Invest. (1999)
- Stromelysin-1 regulates adipogenesis during mammary gland involution. Alexander, C.M., Selvarajan, S., Mudgett, J., Werb, Z. J. Cell Biol. (2001)
- Functional overlap between two classes of matrix-degrading proteases in wound healing. Lund, L.R., Romer, J., Bugge, T.H., Nielsen, B.S., Frandsen, T.L., Degen, J.L., Stephens, R.W., Danø, K. EMBO J. (1999)
- Activity-based probes for the proteomic profiling of metalloproteases. Saghatelian, A., Jessani, N., Joseph, A., Humphrey, M., Cravatt, B.F. Proc. Natl. Acad. Sci. U.S.A. (2004)
- Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor. Barletta, J.P., Angella, G., Balch, K.C., Dimova, H.G., Stern, G.A., Moser, M.T., van Setten, G.B., Schultz, G.S. Invest. Ophthalmol. Vis. Sci. (1996)
- Changes in the expression of extracellular matrix (ECM) and matrix metalloproteinases (MMP) of proliferating rat parotid acinar cells. Broverman, R.L., Nguyen, K.H., da Silveira, A., Brinkley, L.L., Macauley, S.P., Zeng, T., Yamamoto, H., Tarnuzzer, R.W., Schultz, G.S., Kerr, M., Humphreys-Beher, M.G. J. Dent. Res. (1998)
- Matrix metalloproteinase-7 and epidermal growth factor receptor mediate hypoxia-induced extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase activation and subsequent proliferation in bladder smooth muscle cells. Sabha, N., Aitken, K., Lorenzo, A.J., Szybowska, M., Jairath, A., Bägli, D.J. In Vitro Cell. Dev. Biol. Anim. (2006)
- A functional overlap of plasminogen and MMPs regulates vascularization during placental development. Solberg, H., Rinkenberger, J., Danø, K., Werb, Z., Lund, L.R. Development (2003)
- Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. Solorzano, C.C., Ksontini, R., Pruitt, J.H., Hess, P.J., Edwards, P.D., Kaibara, A., Abouhamze, A., Auffenberg, T., Galardy, R.E., Vauthey, J.N., Copeland, E.M., Edwards, C.K., Lauwers, G.Y., Clare-Salzler, M., MacKay, S.L., Moldawer, L.L., Lazarus, D.D. J. Immunol. (1997)
- Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue. Sheridan, C.M., Occleston, N.L., Hiscott, P., Kon, C.H., Khaw, P.T., Grierson, I. Am. J. Pathol. (2001)
- Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Mirastschijski, U., Haaksma, C.J., Tomasek, J.J., Agren, M.S. Exp. Cell Res. (2004)
- Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Bendeck, M.P., Irvin, C., Reidy, M.A. Circ. Res. (1996)
- The proprotein convertase PC5A and a metalloprotease are involved in the proteolytic processing of the neural adhesion molecule L1. Kalus, I., Schnegelsberg, B., Seidah, N.G., Kleene, R., Schachner, M. J. Biol. Chem. (2003)
- Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. Kauppinen, T.M., Swanson, R.A. J. Immunol. (2005)
- Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor. Zeng, L., An, S., Goetzl, E.J. Biochemistry (1996)
- Down-regulated expression of A disintegrin and metalloproteinase with thrombospondin-like repeats-1 by progesterone receptor antagonist is associated with impaired expansion of porcine cumulus-oocyte complexes. Shimada, M., Nishibori, M., Yamashita, Y., Ito, J., Mori, T., Richards, J.S. Endocrinology (2004)
- Proteolytic cleavage of the neural cell adhesion molecule by ADAM17/TACE is involved in neurite outgrowth. Kalus, I., Bormann, U., Mzoughi, M., Schachner, M., Kleene, R. J. Neurochem. (2006)
- In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue. Tremblay, P.L., Berthod, F., Germain, L., Auger, F.A. J. Pharmacol. Exp. Ther. (2005)
- EGF receptor transactivation mediates ANG II-stimulated mitogenesis in intestinal epithelial cells through the PI3-kinase/Akt/mTOR/p70S6K1 signaling pathway. Chiu, T., Santiskulvong, C., Rozengurt, E. Am. J. Physiol. Gastrointest. Liver Physiol. (2005)
- Metalloproteinase shedding of Fas ligand regulates beta-amyloid neurotoxicity. Ethell, D.W., Kinloch, R., Green, D.R. Curr. Biol. (2002)
- Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow. Semino, C.E., Kamm, R.D., Lauffenburger, D.A. Exp. Cell Res. (2006)
- Galardin (GM 6001), a broad-spectrum matrix metalloproteinase inhibitor, blocks bombesin- and LPA-induced EGF receptor transactivation and DNA synthesis in rat-1 cells. Santiskulvong, C., Rozengurt, E. Exp. Cell Res. (2003)
- A matrix metalloproteinase inhibitor prevents processing of tumor necrosis factor alpha (TNF alpha) and abrogates endotoxin-induced lethality. Solorzano, C.C., Ksontini, R., Pruitt, J.H., Auffenberg, T., Tannahill, C., Galardy, R.E., Schultz, G.P., MacKay, S.L., Copeland, E.M., Moldawer, L.L. Shock (1997)
- Prolonged antiscarring effects of ilomastat and MMC after experimental glaucoma filtration surgery. Wong, T.T., Mead, A.L., Khaw, P.T. Invest. Ophthalmol. Vis. Sci. (2005)
- Matrix metalloproteinase activity is required for activity-induced angiogenesis in rat skeletal muscle. Haas, T.L., Milkiewicz, M., Davis, S.J., Zhou, A.L., Egginton, S., Brown, M.D., Madri, J.A., Hudlicka, O. Am. J. Physiol. Heart Circ. Physiol. (2000)
- Effects of matrix metalloproteinase inhibitors on bone resorption and orthodontic tooth movement. Holliday, L.S., Vakani, A., Archer, L., Dolce, C. J. Dent. Res. (2003)
- Matrix metalloproteinases (MMPs) are required for re-epithelialization of cutaneous wounds. Agren, M.S. Arch. Dermatol. Res. (1999)